Table 4.
Multivariable Cox proportional hazards model for two year overall survival.
| Overall | HR | p-Value | [95%CI] |
| mEHT | 0.70 | 0.074 | 0.48–1.03 |
| HIV-negative | 0.82 | 0.328 | 0.54–1.23 |
| Age at Enrolment | 0.97 | 0.007 | 0.95–0.99 |
| FIGO Stage III | 1.01 | 0.785 | 0.71–1.57 |
| FIGO Stage II | HR | p-Value | [95%CI] |
| mEHT | 0.88 | 0.677 | 0.47–1.64 |
| HIV-negative | 0.73 | 0.342 | 0.37–1.41 |
| Age at Enrolment | 0.99 | 0.401 | 0.96–1.02 |
| FIGO Stage III | HR | p-Value | [95%CI] |
| mEHT | 0.61 | 0.047 | 0.37–0.99 |
| HIV-negative | 0.90 | 0.699 | 0.54–1.52 |
| Age at Enrolment | 0.96 | 0.006 | 0.94–0.99 |
Abbreviations: FIGO: Fédération Internationale de Gynécologie et d’Obstétrique; HIV: Human Immunodeficiency Virus; HR: Hazard Ratio; mEHT: Modulated Electro-Hyperthermia.